Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion
about
A patient with heart failure and worsening kidney functionThe growth of acute kidney injury: a rising tide or just closer attention to detail?The kidney in heart failure: an update.Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure TreatmentDecongestion in acute heart failure.Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.Predictors of Recurrent AKI.Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of HemoconcentrationDiagnosis and management of acute heart failureChanges in renal function in congestive heart failure.Determinants of survival following hospitalization for acute heart failure.Do any patients with acute decompensated heart failure and acute cardio-renal syndrome benefit from ultrafiltration?The acute cardiorenal syndrome type I: considerations on physiology, epidemiology, and therapy.Novel renal biomarkers to assess cardiorenal syndromeHypochloremia and Diuretic Resistance in Heart Failure: Mechanistic InsightsBiomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure.Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond.Treatment Approaches to Congestion Relief in Acute Decompensated HF: Insights After DOSE-AHF and CARRESS-HF.SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients.Terminology and definition of changes renal function in heart failure.Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury.Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction.Peripheral Venous Hemoglobin and Red Blood Cell Mass Mismatch in Volume Overload Systolic Heart Failure: Implications for Patient Management.An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.Haemoconcentration as a treatment goal in heart failure: ready for prime time?Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.How to tackle congestion in acute heart failure.Dialyse- und Ultrafiltrationsverfahren bei kardiorenalem Syndrom
P2860
Q34292920-DAAAF9F7-EBD7-4184-BC47-618C5EB30B1AQ34439098-DCC69A81-06B1-4369-9B97-AA7CCB4F9146Q35737499-6562BEE2-D88F-41A7-A992-50B553B276D0Q35762752-398ADF06-191C-497E-8313-BAF528AAD317Q36319066-D0539AE3-2912-4BB6-B4BD-2E7F584235C9Q36445575-C37993AA-BB40-4413-942E-E9849A824711Q36543908-A42D288F-C8F9-4B40-B05C-FFC508F5FE3BQ36746053-3C1CED25-08B9-4845-AFAE-D7D2E1697426Q37206834-E133A1C3-7DD2-4035-8B94-BD5A82E368E9Q37680530-388A307B-A1DB-4413-A8A7-2DB175E5EC73Q38155422-8F481CD0-DFE6-4283-9B40-90F9A2D56F31Q38183318-68F0F2C9-3C05-4AA9-8CC3-13E1C15E23ACQ38195309-9E8499C7-6487-41BC-91A2-B67DF75B29D6Q38249914-D11DDB3E-72EC-4878-8A9F-B7117E7CD955Q38252731-13E20260-A4EE-4934-AB31-4DBA3E0510B4Q38389041-3F0DEF96-82B5-4CD3-89D1-A6DB251F95D5Q38626779-203C3469-7E0E-48E0-9778-A8CC85607377Q38744467-53DB3418-0E41-4B86-A1A3-173BE5151EFFQ39203291-BD9C8CE5-7A42-41EE-9FB3-F7A8C175C552Q39408236-143BD0FA-A28B-4A30-867D-BF3D9B52D952Q41594870-21C93A77-2901-4463-AC08-71551C741E34Q42686685-79496F34-D92D-4AE2-A94C-560ED13C831DQ49911745-6C88980C-1101-442B-8382-0C6123B34AA7Q50209292-B93D39CF-9782-416E-8070-8B1CE2D93A25Q50437430-808B0DBC-AC84-4BFF-8EE5-93E4126AC784Q50660691-A862D849-CBFC-4CB2-BD53-B27AE965E3C2Q50914234-B91C42BA-B1AA-4636-8228-FF856540A03BQ50925604-9EF490D1-0843-47F3-B7AA-9251323AFA52Q51376676-AC1A1E68-CF41-43A6-B18D-CB9205DAC6B6Q55036577-D05F6776-76D7-4523-A314-CC9E09503D35Q56686665-D8D9807F-5BB4-4A89-8F2C-07C93493C71C
P2860
Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Timing of hemoconcentration du ...... ance of sustained decongestion
@en
Timing of hemoconcentration du ...... nce of sustained decongestion.
@nl
type
label
Timing of hemoconcentration du ...... ance of sustained decongestion
@en
Timing of hemoconcentration du ...... nce of sustained decongestion.
@nl
prefLabel
Timing of hemoconcentration du ...... ance of sustained decongestion
@en
Timing of hemoconcentration du ...... nce of sustained decongestion.
@nl
P2093
P2860
P1476
Timing of hemoconcentration du ...... ance of sustained decongestion
@en
P2093
Brian D McCauley
Chirag R Parikh
Jeffrey M Testani
Jennifer Chen
Meredith A Brisco
W H Wilson Tang
P2860
P304
P356
10.1016/J.JACC.2013.05.027
P407
P577
2013-06-07T00:00:00Z